Cargando…

Dihydroartemisinin-Loaded Magnetic Nanoparticles for Enhanced Chemodynamic Therapy

Recently, chemodynamic therapy (CDT) has represented a new approach for cancer treatment with low toxicity and side effects. Nonetheless, it has been a challenge to improve the therapeutic effect through increasing the amount of reactive oxygen species (ROS). Herein, we increased the amount of ROS a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Shengdi, Yao, Xianxian, Jiang, Qin, Wang, Kuang, Zhang, Yuanying, Peng, Haibao, Tang, Jing, Yang, Wuli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076125/ https://www.ncbi.nlm.nih.gov/pubmed/32210814 http://dx.doi.org/10.3389/fphar.2020.00226

Ejemplares similares

Nanosystems for chemodynamic based combination therapy: Strategies and recent advances
por: Li, Minghui, et al.
Publicado: (2022)

Mitochondria-Targeting Chemodynamic Therapy Nanodrugs for Cancer Treatment
por: Chen, Qiaohui, et al.
Publicado: (2022)

Targeted Lipid Nanoparticles Encapsulating Dihydroartemisinin and Chloroquine Phosphate for Suppressing the Proliferation and Liver Metastasis of Colorectal Cancer
por: Peng, Jianqing, et al.
Publicado: (2021)

A multifunctional oxidative stress nanoamplifier with ROS amplification and GSH exhaustion for enhanced chemodynamic therapy
por: Zhong, Wenzhao, et al.
Publicado: (2022)

Simvastatin induced ferroptosis for triple-negative breast cancer therapy
por: Yao, Xianxian, et al.
Publicado: (2021)

Injectable Hydrogel for NIR-II Photo-Thermal Tumor Therapy and Dihydroartemisinin-Mediated Chemodynamic Therapy
por: Chen, Danyang, et al.
Publicado: (2020)

A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin
por: Yang, Xiao-Xin, et al.
Publicado: (2022)

Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells
por: Huang, Tzu-En, et al.
Publicado: (2020)

Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer
por: Li, Qingrong, et al.
Publicado: (2021)

Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine
por: Permala, Jesmin, et al.
Publicado: (2017)

CuS nanoparticles and camptothecin co-loaded thermosensitive injectable hydrogel with self-supplied H(2)O(2) for enhanced chemodynamic therapy
por: Tang, Wenxue, et al.
Publicado: (2022)

Hydrogel co-loading SO(2) prodrug and FeGA nanoparticles for enhancing chemodynamic therapy by photothermal-triggered SO(2) gas therapy
por: Huang, Qinqin, et al.
Publicado: (2022)

Chemical Factory‐Guaranteed Enhanced Chemodynamic Therapy for Orthotopic Liver Cancer
por: Tang, Zhongmin, et al.
Publicado: (2022)

Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage
por: Li, Liu-Gen, et al.
Publicado: (2022)

Doxorubicin-Loaded Metal-Organic Framework Nanoparticles as Acid-Activatable Hydroxyl Radical Nanogenerators for Enhanced Chemo/Chemodynamic Synergistic Therapy
por: Li, Honghui, et al.
Publicado: (2022)

Strategies for enhancing cancer chemodynamic therapy performance
por: Jana, Deblin, et al.
Publicado: (2022)

Three-Carbon Linked Dihydroartemisinin-Isatin Hybrids: Design, Synthesis and Their Antiproliferative Anticancer Activity
por: Dong, Min, et al.
Publicado: (2022)

Dihydroartemisinin Inhibits Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular AMD
por: Li, Xun, et al.
Publicado: (2022)

Metabolite Profiling of Dihydroartemisinin in Blood of Plasmodium-Infected and Healthy Mice Using UPLC-Q-TOF-MS(E)
por: Zhao, Yifan, et al.
Publicado: (2021)

Iron Promotes Dihydroartemisinin Cytotoxicity via ROS Production and Blockade of Autophagic Flux via Lysosomal Damage in Osteosarcoma
por: Shen, Ying, et al.
Publicado: (2020)

Bovine serum albumin-templated nanoplatform for magnetic resonance imaging-guided chemodynamic therapy
por: Tang, Wei, et al.
Publicado: (2019)

Dihydroartemisinin-Loaded Chitosan Nanoparticles Inhibit the Rifampicin-Resistant Mycobacterium tuberculosis by Disrupting the Cell Wall
por: Gu, Xiujuan, et al.
Publicado: (2021)

H(2)O(2)-independent chemodynamic therapy initiated from magnetic iron carbide nanoparticle-assisted artemisinin synergy
por: Zhao, Fan, et al.
Publicado: (2021)

Pharmacokinetic Properties of Artemether, Dihydroartemisinin, Lumefantrine, and Quinine in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria in Uganda
por: Tarning, Joel, et al.
Publicado: (2013)

Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria
por: Lohy Das, Jesmin, et al.
Publicado: (2018)

Inhibitory Effect of Dihydroartemisinin on the Proliferation and Migration of Melanoma Cells and Experimental Lung Metastasis From Melanoma in Mice
por: Zhang, Qi, et al.
Publicado: (2021)

Dihydroartemisinin Alleviates Imiquimod-Induced Psoriasis-like Skin Lesion in Mice Involving Modulation of IL-23/Th17 Axis
por: Liu, Jiang-Min, et al.
Publicado: (2021)

Berberine-Loaded Biomimetic Nanoparticles Attenuate Inflammation of Experimental Allergic Asthma via Enhancing IL-12 Expression
por: Jin, Hua, et al.
Publicado: (2021)

Environmental chemodynamics : movement of chemicals in air, water, and soil /
por: Thibodeaux, Louis J.
Publicado: (1996)

Design, Synthesis and Anti-Lung Cancer Evaluation of 1, 2, 3-Triazole Tethered Dihydroartemisinin-Isatin Hybrids
por: Hou, Haodong, et al.
Publicado: (2021)

Estimation of dihydroartemisinin in human plasma using a highly sensitive LTQ Orbitrap mass spectrometer with Xcalibur software
por: Abu-Izneid, Tareq, et al.
Publicado: (2023)

Tumor Microenvironment-Adaptive Nanoplatform Synergistically Enhances Cascaded Chemodynamic Therapy
por: Wang, Yuemin, et al.
Publicado: (2022)

Chemodynamic nanomaterials for cancer theranostics
por: Xin, Jingqi, et al.
Publicado: (2021)

Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2019)

Enhanced Anti-tumor of Pep-1 Modified Superparamagnetic Iron Oxide/PTX Loaded Polymer Nanoparticles
por: Wang, Baoyan, et al.
Publicado: (2019)

Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether
por: Watson, Daniel J., et al.
Publicado: (2021)

Cu(2+)-Chelating Mesoporous Silica Nanoparticles for Synergistic Chemotherapy/Chemodynamic Therapy
por: Zhang, Yanyan, et al.
Publicado: (2022)

Myriocin enhances the antifungal activity of fluconazole by blocking the membrane localization of the efflux pump Cdr1
por: Wang, Hongkang, et al.
Publicado: (2022)

Drug-loaded PEG-PLGA nanoparticles for cancer treatment
por: Zhang, Dan, et al.
Publicado: (2022)

Remodeling of tumor microenvironment for enhanced tumor chemodynamic/photothermal/chemo-therapy
por: Zhang, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rkel4rtto7sbv2lofsribve9db